{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:52:21Z","timestamp":1772754741589,"version":"3.50.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Neutropenia and agranulocytosis are rare side effects of deferiprone (DFP) in patients treated for iron overload. Unfortunately, no study directly addressed special risks in countries with a background of ethnic neutropenia, such as Oman.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim:<\/jats:title>\n            <jats:p>The aim of this study was to report the incidence of neutropenia in Omani children with \u03b2-thalassemia treated with different iron chelators.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/Design:<\/jats:title>\n            <jats:p>This was a retrospective study that included 179 Omani pediatric patients. For patients who developed neutropenia, demographic data, iron-chelating agent, clinical presentation, management, and outcome were recorded. Detailed clinical, laboratory\u00b1radiologic information was added for patients with agranulocytosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Neutropenia was encountered in 43.6% of patients: severe neutropenia in 10 patients, moderate in 29, and mild in 69 patients. Severe and moderate neutropenia had similar incidence among DFP-exposed and DFP-naive patients (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.515 and 0.421, respectively), while mild neutropenia was common among DFP-naive patients (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.0001). A higher incidence of DFP-related agranulocytosis (4.1%) was noted compared with previous reports, but none had a fatal outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In a community with ethnic neutropenia, mild to moderate neutropenia is common. Higher incidence of severe neutropenia and agranulocytosis mandates careful monitoring and rational modification of iron-chelating agents to avoid life-threatening complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000001699","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T19:14:03Z","timestamp":1577214843000},"page":"e750-e755","source":"Crossref","is-referenced-by-count":4,"title":["Neutropenia and Life-threatening Agranulocytosis Among Children With \u03b2-Thalassemia Treated With Oral Iron Chelators in a Community With Background of Ethnic Neutropenia"],"prefix":"10.1097","volume":"42","author":[{"given":"Hanan F.","family":"Nazir","sequence":"first","affiliation":[{"name":"Child Health"},{"name":"Department of Pediatrics, Alexandria Faculty of Medicine, Alexandria, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Alshizawi","sequence":"additional","affiliation":[{"name":"Nursing, Sultan Qaboos University Hospital, Muscat, Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/2040620712450252","article-title":"Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia","volume":"3","author":"Jamuar","year":"2012","journal-title":"Ther Adv Hematol"},{"key":"R2-20230918","first-page":"3","article-title":"Prevalence, phenotype and inheritance of benign neutropenia in Arabs","volume":"9","author":"Denic","year":"2009","journal-title":"BMC Blood Disord"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/ejh.12241","article-title":"Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a more severe drop in neutrophil count","volume":"92","author":"El-Beshlawy","year":"2014","journal-title":"Eur J Haematol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/ajh.24479","article-title":"Deferiprone-induced agranulocytosis: 20 years of clinical observations","volume":"91","author":"Tricta","year":"2016","journal-title":"Am J Hematol"},{"key":"R5-20230918","first-page":"275","article-title":"Agranulocytosis in beta thalassemia major patients treated with oral iron chelating agent deferiprone","volume":"23","author":"Wali","year":"2008","journal-title":"Oman Med J"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/pbc.24920","article-title":"Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis","volume":"61","author":"Elalfy","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/blood-2007-02-065805","article-title":"Fatal agranulocytosis after deferiprone therapy in a child with Diamond-Blackfan anemia","volume":"109","author":"Henter","year":"2007","journal-title":"Blood"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1200\/JCO.2009.24.3881","article-title":"Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?","volume":"28","author":"Hsieh","year":"2010","journal-title":"J Clin Oncol"},{"key":"R9-20230918","first-page":"462","article-title":"Agranulocytosis due to deferiprone: a case report with cytomorphological and functional bone marrow examination","volume":"9","author":"Masera","year":"2011","journal-title":"Blood Transfus"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:36:42Z","timestamp":1695015402000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,23]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001699","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,23]]}}}